A Study of CDX-0159 in Patients With Prurigo Nodularis
NCT04944862
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Prurigo Nodularis
Interventions
BIOLOGICAL:
CDX-0159
DRUG:
Normal saline
Sponsor
Celldex Therapeutics